{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:16:01Z","timestamp":1790144161328,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010677","name":"EU","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Methods &amp; Clinical Development"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.omtm.2025.101605","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T23:14:34Z","timestamp":1759792474000},"page":"101605","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions"],"prefix":"10.1016","volume":"33","author":[{"given":"Maaike","family":"Suuring","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giada","family":"Amodio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Rouel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Raux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Delhaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lise","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Cloteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denisia","family":"Lavercan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rondeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Chiffoleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Santoni de Sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika\u00ebl","family":"Croyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8519-2632","authenticated-orcid":false,"given":"Aur\u00e9lie","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2025.101605_bib1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2215\/CJN.04950610","article-title":"Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility","volume":"6","author":"Perico","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2025.101605_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/tri.12132","article-title":"Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation","volume":"26","author":"Perico","year":"2013","journal-title":"Transpl. Int."},{"key":"10.1016\/j.omtm.2025.101605_bib3","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/jama.2012.316","article-title":"Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial","volume":"307","author":"Tan","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.omtm.2025.101605_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5966\/sctm.2012-0114","article-title":"Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study","volume":"2","author":"Reinders","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.omtm.2025.101605_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/TP.0b013e3182754c53","article-title":"Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: a clinical pilot study","volume":"95","author":"Peng","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.omtm.2025.101605_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nep.12338","article-title":"Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: a pilot study","volume":"20","author":"Mudrabettu","year":"2015","journal-title":"Nephrol. Carlton Vic"},{"key":"10.1016\/j.omtm.2025.101605_bib7","doi-asserted-by":"crossref","first-page":"12089","DOI":"10.18632\/oncotarget.7725","article-title":"Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study","volume":"7","author":"Pan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omtm.2025.101605_bib8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.3389\/fimmu.2018.01359","article-title":"Long-Term Clinical and Immunological Profile of Kidney Transplant Patients Given Mesenchymal Stromal Cell Immunotherapy","volume":"9","author":"Perico","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101605_bib10","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1182\/blood-2010-10-311894","article-title":"Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation","volume":"117","author":"Di Ianni","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101605_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib12","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.28459","article-title":"A pilot study of operational tolerance with a regulatory T-cell-based cell therapy in living donor liver transplantation","volume":"64","author":"Todo","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2025.101605_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2022020210","article-title":"Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients","volume":"34","author":"Morath","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.omtm.2025.101605_bib14","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1172\/JCI133595","article-title":"Phase I trial of donor-derived modified immune cell infusion in kidney transplantation","volume":"130","author":"Morath","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtm.2025.101605_bib15","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.omtm.2025.101605_bib16","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.omtm.2025.101605_bib17","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1073\/pnas.1820039116","article-title":"Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2025.101605_bib18","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/annrheumdis-2018-eular.2880","article-title":"SAT0212 The safety and tolerability of intra-articular injection of tolerogenic dendritic cells in patients with rheumatoid arthritis: the preliminary results","volume":"77","author":"Kurochkina","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.omtm.2025.101605_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtm.2025.101605_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.omtm.2025.101605_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-030309","article-title":"Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration","volume":"9","author":"Willekens","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.omtm.2025.101605_bib22","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/ecco-jcc\/jjv144","article-title":"Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn\u2019s Disease: A Phase I Study","volume":"9","author":"Jauregui-Amezaga","year":"2015","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.omtm.2025.101605_bib23","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/TP.0000000000003315","article-title":"Preclinical assessment of Autologous Tolerogenic Dendritic Cells from End-stage renal disease patients","volume":"105","author":"Bouchet-Delbos","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.omtm.2025.101605_bib24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3389\/fimmu.2020.01260","article-title":"Generation of Powerful Human Tolerogenic Dendritic Cells by Lentiviral-Mediated IL-10 Gene Transfer","volume":"11","author":"Comi","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.it.2020.11.001","article-title":"Tolerogenic Dendritic Cells in Autoimmunity and Inflammatory Diseases","volume":"42","author":"Morante-Palacios","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib26","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fimmu.2018.00274","article-title":"Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?","volume":"9","author":"Mar\u00edn","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.cmet.2019.11.011","article-title":"Human Tolerogenic Dendritic Cells Regulate Immune Responses through Lactate Synthesis","volume":"30","author":"Marin","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.omtm.2025.101605_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/08830185.2010.522280","article-title":"Novel findings in drug-induced dendritic cell tolerogenicity","volume":"29","author":"Svajger","year":"2010","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fimmu.2014.00007","article-title":"Regulatory dendritic cells for immunotherapy in immunologic diseases","volume":"5","author":"Gordon","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib30","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.4049\/jimmunol.162.11.6473","article-title":"Glucocorticoids affect human dendritic cell differentiation and maturation","volume":"162","author":"Piemonti","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/intimm\/dxh215","article-title":"Mycophenolic acid-treated human dendritic cells have a mature migratory phenotype and inhibit allogeneic responses via direct and indirect pathways","volume":"17","author":"Lagaraine","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mcn.2013.03.005","article-title":"Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1\/Th17 to Th2 cytokines","volume":"56","author":"Li","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.omtm.2025.101605_bib33","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.4049\/jimmunol.1303073","article-title":"All-trans retinoic acid induces arginase-1 and inducible nitric oxide synthase-producing dendritic cells with T cell inhibitory function","volume":"192","author":"Bhatt","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib34","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3349\/ymj.2018.59.7.807","article-title":"Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells","volume":"59","author":"Kim","year":"2018","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.omtm.2025.101605_bib35","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.0902133","article-title":"Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells","volume":"184","author":"Torres-Aguilar","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib36","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4049\/jimmunol.1103286","article-title":"Induction of prolonged asthma tolerance by IL-10-differentiated dendritic cells: differential impact on airway hyperresponsiveness and the Th2 immunoinflammatory response","volume":"189","author":"Nayyar","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/2047-1440-1-13","article-title":"Cell therapy using tolerogenic dendritic cells in transplantation","volume":"1","author":"Moreau","year":"2012","journal-title":"Transplant. Res."},{"key":"10.1016\/j.omtm.2025.101605_bib38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2009-07-234872","article-title":"Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4\/HLA-G pathway","volume":"116","author":"Gregori","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101605_bib39","first-page":"3070","article-title":"Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates","volume":"23","author":"Moreau","year":"2009","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.omtm.2025.101605_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.28","article-title":"Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transfer","volume":"1","author":"Moreau","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2025.101605_bib41","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.kint.2022.08.037","article-title":"A Phase I\/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients","volume":"103","author":"Moreau","year":"2023","journal-title":"Kidney Int."},{"key":"10.1016\/j.omtm.2025.101605_bib42","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8","article-title":"Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo","volume":"30","author":"Lutz","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib43","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood-2004-03-1211","article-title":"Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells","volume":"105","author":"Levings","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.omtm.2025.101605_bib44","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/1521-4141(200006)30:6<1769::AID-IMMU1769>3.0.CO;2-9","article-title":"IL-10 induces apoptosis in human monocytes involving the CD95 receptor\/ligand pathway","volume":"30","author":"Schmidt","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib45","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.4049\/jimmunol.178.12.7794","article-title":"Exposure of myeloid dendritic cells to exogenous or endogenous IL-10 during maturation determines their longevity","volume":"178","author":"Chang","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib46","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.4049\/jimmunol.167.7.3619","article-title":"IL-10 inhibits granulocyte-macrophage colony-stimulating factor-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages","volume":"167","author":"Hashimoto","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib47","doi-asserted-by":"crossref","first-page":"682","DOI":"10.3389\/fimmu.2018.00682","article-title":"Interleukin-10-Producing DC-10 Is a Unique Tool to Promote Tolerance Via Antigen-Specific T Regulatory Type 1 Cells","volume":"9","author":"Comi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib48","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The Biology of T Regulatory Type 1 Cells and Their Therapeutic Application in Immune-Mediated Diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.omtm.2025.101605_bib49","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.mad.2003.11.013","article-title":"The immunoregulatory effects of homocysteine and its intermediates on T-lymphocyte function","volume":"125","author":"Dawson","year":"2004","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.omtm.2025.101605_bib50","first-page":"585","article-title":"Immunoregulatory effects of homocysteine on cardiovascular diseases","volume":"59","author":"Dai","year":"2007","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.omtm.2025.101605_bib51","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.3390\/ijms241411236","article-title":"Glycine: The Smallest Anti-Inflammatory Micronutrient","volume":"24","author":"Aguayo-Cer\u00f3n","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101605_bib52","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2025.101605_bib53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","article-title":"Metabolic regulation of immune responses","volume":"32","author":"Ganeshan","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.omtm.2025.101605_bib54","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1873-3468.15017","article-title":"Leveraging current insights on IL-10-producing dendritic cells for developing effective immunotherapeutic approaches","volume":"599","author":"Morali","year":"2025","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtm.2025.101605_bib55","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.3390\/ijms22147363","article-title":"Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator","volume":"22","author":"Mansilla","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtm.2025.101605_bib56","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/bioinformatics\/btu813","article-title":"Workflow4Metabolomics: a collaborative research infrastructure for computational metabolomics","volume":"31","author":"Giacomoni","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.omtm.2025.101605_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005752","article-title":"mixOmics: An R package for \u2019omics feature selection and multiple data integration","volume":"13","author":"Rohart","year":"2017","journal-title":"PLoS Comput. Biol."}],"container-title":["Molecular Therapy Methods &amp; Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125002001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050125002001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:29:56Z","timestamp":1776198596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050125002001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2329050125002001"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101605","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2025.101605","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"101605"}}